A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study.

Journal Information

Full Title: Crit Care Resusc

Abbreviation: Crit Care Resusc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that they have no competing interests."

Evidence found in paper:

"Funding Funding for this study has been provided by the 10.13039/501100001704European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the Royal Brisbane and Women's Hospital Research Foundation. Gilead Fellowship to Dr FB Sime. Participating sites will not receive a per-patient payment. 10.13039/501100001794The University of Queensland (coordinating centre) will fund sample transport from the participating site and will also fund assaying of the samples."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025